| European Case Law Identifier: | ECLI:EP:BA:2018:T060514.20180607 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 07 June 2018 | ||||||||
| Case number: | T 0605/14 | ||||||||
| Application number: | 05854387.7 | ||||||||
| IPC class: | C07K 16/22 C07K 16/28 C12N 15/13 C12N 15/85 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Antibodies directed to angiopoietin-2 and uses thereof | ||||||||
| Applicant name: | Medimmune Limited | ||||||||
| Opponent name: | F.Hoffmann-La Roche AG | ||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Main request, auxiliary requests 1 to 6 - inventive step (no) | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t140605eu1.html
Date retrieved: 17 May 2021